Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(4)
Other(2)

Detailed Status

Completed4
unknown2
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (14.3%)
N/A6 (85.7%)

Trials by Status

completed450%
active_not_recruiting113%
recruiting113%
unknown225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
PROCEDURE
Total Trials
8